FDA To Advise New NIH/Biopharmaceutical Partnership On Immunotherapy

FDA will help serve in an advisory role for a new public-private partnership between the National Institutes of Health (NIH) and 11 major biopharmaceutical companies. The goal of the partnership, which is part of the Cancer Moonshot initiative, is to “identify, develop and validate robust biomarkers” to advance the development of immunotherapies to treat cancer, NIH announced Thursday (Oct. 12). The Partnership For Accelerating Cancer Therapies (PACT) is a five-year partnership “totaling $215 million as part of the Cancer Moonshot,”...